<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37864020</PMID><DateCompleted><Year>2024</Year><Month>05</Month><Day>23</Day></DateCompleted><DateRevised><Year>2024</Year><Month>05</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-2129</ISSN><JournalIssue CitedMedium="Internet"><Volume>38</Volume><Issue>3</Issue><PubDate><Year>2024</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Schmerz (Berlin, Germany)</Title><ISOAbbreviation>Schmerz</ISOAbbreviation></Journal><ArticleTitle>[Interdisciplinary multimodal pain therapy in postviral syndromes and ME/CFS : Features, pitfalls and model concept].</ArticleTitle><Pagination><StartPage>183</StartPage><EndPage>189</EndPage><MedlinePgn>183-189</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00482-023-00761-2</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Multimodal pain therapy usually take place in the context of group therapy lasting several weeks and is based on a&#xa0;generally activating approach. Due to the specificity of stress intolerance with postexertional malaise (PEM) in patients with postviral syndromes, physical as well as psychological overload must be urgently avoided in these cases; however, these aspects can only be insufficiently considered in current medical pain therapy concepts.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Summary of the current literature and presentation of clinical characteristics as well as presentation of a&#xa0;model project for a&#xa0;multimodal pain therapy in postviral syndromes with PEM.</AbstractText><AbstractText Label="MODEL CONCEPT" NlmCategory="UNASSIGNED">The presented model project describes a&#xa0;day clinic treatment setting for interdisciplinary multimodal pain therapy adapted to the individual resilience with minimization of the risk of strain-induced deterioration of the condition.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Luchting</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-8919-9874</Identifier><AffiliationInfo><Affiliation>Interdisziplin&#xe4;re Schmerztagesklinik der M&#xfc;nchen Klinik Schwabing, Klinik f&#xfc;r An&#xe4;sthesiologie, Kinderan&#xe4;sthesiologie und Operative Intensivmedizin, M&#xfc;nchen Klinik Schwabing, M&#xfc;nchen, Deutschland. dr.benjamin@luchting.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Behrends</LastName><ForeName>Uta</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>MRI Chronische Fatigue Centrum f&#xfc;r junge Menschen. Zentrum f&#xfc;r Kinder- und Jugendmedizin, Technische Universit&#xe4;t M&#xfc;nchen und M&#xfc;nchen Klinik, M&#xfc;nchen, Deutschland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eigner</LastName><ForeName>Bianca</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Interdisziplin&#xe4;re Schmerztagesklinik der M&#xfc;nchen Klinik Schwabing, Klinik f&#xfc;r An&#xe4;sthesiologie, Kinderan&#xe4;sthesiologie und Operative Intensivmedizin, M&#xfc;nchen Klinik Schwabing, M&#xfc;nchen, Deutschland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stojanov</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>MRI Chronische Fatigue Centrum f&#xfc;r junge Menschen. Zentrum f&#xfc;r Kinder- und Jugendmedizin, Technische Universit&#xe4;t M&#xfc;nchen und M&#xfc;nchen Klinik, M&#xfc;nchen, Deutschland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Warlitz</LastName><ForeName>Cordula</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>MRI Chronische Fatigue Centrum f&#xfc;r junge Menschen. Zentrum f&#xfc;r Kinder- und Jugendmedizin, Technische Universit&#xe4;t M&#xfc;nchen und M&#xfc;nchen Klinik, M&#xfc;nchen, Deutschland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haegele</LastName><ForeName>Matthias</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>MRI Chronische Fatigue Centrum f&#xfc;r junge Menschen. Zentrum f&#xfc;r Kinder- und Jugendmedizin, Technische Universit&#xe4;t M&#xfc;nchen und M&#xfc;nchen Klinik, M&#xfc;nchen, Deutschland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neuwirth</LastName><ForeName>Eva</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Interdisziplin&#xe4;re Schmerztagesklinik der M&#xfc;nchen Klinik Schwabing, Klinik f&#xfc;r An&#xe4;sthesiologie, Kinderan&#xe4;sthesiologie und Operative Intensivmedizin, M&#xfc;nchen Klinik Schwabing, M&#xfc;nchen, Deutschland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mihatsch</LastName><ForeName>Lorenz</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>MRI Chronische Fatigue Centrum f&#xfc;r junge Menschen. Zentrum f&#xfc;r Kinder- und Jugendmedizin, Technische Universit&#xe4;t M&#xfc;nchen und M&#xfc;nchen Klinik, M&#xfc;nchen, Deutschland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Richter</LastName><ForeName>Hans Peter</ForeName><Initials>HP</Initials><AffiliationInfo><Affiliation>Interdisziplin&#xe4;re Schmerztagesklinik der M&#xfc;nchen Klinik Schwabing, Klinik f&#xfc;r An&#xe4;sthesiologie, Kinderan&#xe4;sthesiologie und Operative Intensivmedizin, M&#xfc;nchen Klinik Schwabing, M&#xfc;nchen, Deutschland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Klinik und Poliklinik f&#xfc;r An&#xe4;sthesiologie und Intensivmedizin, Technische Universit&#xe4;t M&#xfc;nchen, M&#xfc;nchen, Deutschland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>ger</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><VernacularTitle>Interdisziplin&#xe4;re multimodale Schmerztherapie bei postviralen Syndromen und ME/CFS : Besonderheiten, Fallstricke und Modellkonzept.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Schmerz</MedlineTA><NlmUniqueID>8906258</NlmUniqueID><ISSNLinking>0932-433X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003131" MajorTopicYN="N">Combined Modality Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000070516" MajorTopicYN="Y">Intersectoral Collaboration</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D033183" MajorTopicYN="Y">Interdisciplinary Communication</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059408" MajorTopicYN="Y">Pain Management</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010348" MajorTopicYN="N">Patient Care Team</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016262" MajorTopicYN="N">Postpoliomyelitis Syndrome</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011615" MajorTopicYN="N">Psychotherapy, Group</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003299" MajorTopicYN="N">Cooperative Behavior</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003291" MajorTopicYN="N">Conversion Disorder</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="ger"><AbstractText Label="ZUSAMMENFASSUNG" NlmCategory="UNASSIGNED">HINTERGRUND: Multimodale Schmerztherapien erfolgen &#xfc;blicherweise im Rahmen von mehrw&#xf6;chigen Gruppentherapien und basieren auf einem generell aktivierenden Ansatz. Durch die Besonderheit einer Belastungsintoleranz mit postexertioneller Malaise (PEM) bei Patient:innen mit postviralen Syndromen muss in diesen F&#xe4;llen eine k&#xf6;rperliche sowie psychische &#xdc;berlastung dringend vermieden werden. Diese Aspekte k&#xf6;nnen in g&#xe4;ngigen schmerzmedizinischen Therapiekonzepten jedoch nur unzureichend ber&#xfc;cksichtigt werden.</AbstractText><AbstractText Label="METHODIK" NlmCategory="METHODS">Zusammenfassung der aktuellen Literatur und Darstellung klinischer Besonderheiten sowie Vorstellung eines therapeutischen Modellprojekts f&#xfc;r eine interdisziplin&#xe4;re multimodale Schmerztherapie bei postviralen Syndromen mit PEM.</AbstractText><AbstractText Label="MODELLKONZEPT" NlmCategory="UNASSIGNED">Das vorgestellte Modellkonzept beschreibt ein der individuellen Belastbarkeit angepasstes tagesklinisches Behandlungssetting f&#xfc;r die multimodale Schmerztherapie mit Minimierung des Risikos einer belastungsinduzierten Zustandsverschlechterung.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Myalgic encephalomyelitis/chronic fatigue syndrome</Keyword><Keyword MajorTopicYN="N">Pain</Keyword><Keyword MajorTopicYN="N">Post-COVID/Long-COVID</Keyword><Keyword MajorTopicYN="N">Stress intolerance</Keyword><Keyword MajorTopicYN="N">Therapy concept</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>23</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>21</Day><Hour>5</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>20</Day><Hour>23</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>10</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37864020</ArticleId><ArticleId IdType="pmc">PMC11116220</ArticleId><ArticleId IdType="doi">10.1007/s00482-023-00761-2</ArticleId><ArticleId IdType="pii">10.1007/s00482-023-00761-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Arnold B, Brinkschmidt T, Casser HR, et al. Multimodal pain therapy: principles and indications. Schmerz. 2009;23:112&#x2013;120. doi: 10.1007/s00482-008-0741-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00482-008-0741-x</ArticleId><ArticleId IdType="pubmed">19156448</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonilla H, Quach TC, Tiwari A, et al. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome is common in post-acute sequelae of SARS-coV-2 infection (PASC): results from a&#xa0;post-COVID-19 multidisciplinary clinic. Front Neurol. 2023;14:1090747. doi: 10.3389/fneur.2023.1090747.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2023.1090747</ArticleId><ArticleId IdType="pmc">PMC9998690</ArticleId><ArticleId IdType="pubmed">36908615</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevetion . Symptoms and Diagnosis of ME/CFS. In: CDC; 2021.</Citation></Reference><Reference><Citation>Cotler J, Holtzman C, Dudun C et al (2018) A brief questionnaire to assess post-exertional malaise. Diagnostics (basel) 8:</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6165517</ArticleId><ArticleId IdType="pubmed">30208578</ArticleId></ArticleIdList></Reference><Reference><Citation>Cutler DM. The costs of long COVID. Jama Health Forum. 2022;3:e221809. doi: 10.1001/jamahealthforum.2022.1809.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamahealthforum.2022.1809</ArticleId><ArticleId IdType="pubmed">36219031</ArticleId></ArticleIdList></Reference><Reference><Citation>Diehl R, Haubrich C, Steinhoff B, et al. Synkopen, S1-Leitlinie. editors. Leitlinien f&#xfc;r Diagnostik und Therapie in der Neurologie: Deutsche Gesellschaft f&#xfc;r Neurologieet al; 2020.</Citation></Reference><Reference><Citation>Garc&#xed;a-Azor&#xed;n D, Sierra &#xc1;, Trigo J, et al. Frequency and phenotype of headache in covid-19: a&#xa0;study of 2194 patients. Sci Rep. 2021;11:14674. doi: 10.1038/s41598-021-94220-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-94220-6</ArticleId><ArticleId IdType="pmc">PMC8290038</ArticleId><ArticleId IdType="pubmed">34282206</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez-Hermosillo JA, Mart&#xed;nez-L&#xf3;pez JP, Carrillo-Lamp&#xf3;n SA, et al. Post-acute COVID-19&#xa0;symptoms, a&#xa0;potential link with myalgic encephalomyelitis/chronic fatigue syndrome: a&#xa0;6-month survey in a&#xa0;Mexican cohort. Brain Sci. 2021;11:760. doi: 10.3390/brainsci11060760.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci11060760</ArticleId><ArticleId IdType="pmc">PMC8227652</ArticleId><ArticleId IdType="pubmed">34201087</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez-Martinez A, Guerrero-Peral &#xc1;L, Arias-Rivas S, et al. Amitriptyline for post-COVID headache: effectiveness, tolerability, and response predictors. J Neurol. 2022;269:5702&#x2013;5709. doi: 10.1007/s00415-022-11225-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-022-11225-5</ArticleId><ArticleId IdType="pmc">PMC9553757</ArticleId><ArticleId IdType="pubmed">35829760</ArticleId></ArticleIdList></Reference><Reference><Citation>Grande T, Grande B, Gerner P, et al. The role of psychotherapy in the care of patients with Myalgic encephalomyelitis/chronic fatigue syndrome. Ann Univ Mariae Curie Sklodowska [Med] 2023;59:719.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10145115</ArticleId><ArticleId IdType="pubmed">37109676</ArticleId></ArticleIdList></Reference><Reference><Citation>Grobe TG, Bessel S, Institut f&#xfc;r angewandte Qualit&#xe4;tsf&#xf6;rderung und Forschung (2022) Jahre Coronapandemie: Wie geht es Deutschlands Besch&#xe4;ftigten? Teil&#xa0;2. In: Techniker Krankenkasse. https://www.tk.de/resource/blob/2130932/70a0d93d19f6444f06310379441bd046/gesundheitsreport-2022-data.pdf. Zugegriffen: 16. Sept. 2023</Citation></Reference><Reference><Citation>Hallek M, Adorjan K, Behrends U, et al. Post-COVID Syndrome. Dtsch &#xc4;rztebl Int. 2023;120:48&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10060997</ArticleId><ArticleId IdType="pubmed">36633452</ArticleId></ArticleIdList></Reference><Reference><Citation>Houlton A, Christie MM, Smith B, et al. Long-term follow-up of multi-disciplinary outpatient treatment for chronic fatigue syndrome/myalgic encephalopathy. Fatigue: Biomed Health Behav. 2015;3:47&#x2013;58.</Citation></Reference><Reference><Citation>Institut f&#xfc;r Qualit&#xe4;t und Wirtschaftlichkeit im Gesundheitswesen (2023) Myalgische Enzephalomyelitis / Chronic Fatigue Syndrome (ME/CFS) &#x2013; Aktueller Kenntnisstand. In:Institut f&#xfc;r Qualit&#xe4;t und Wirtschaftlichkeit im Gesundheitswesen. https://www.iqwig.de/download/n21-01_me-cfs-aktueller-kenntnisstand_abschlussbericht_v1-0.pdf. Zugegriffen: 16. Sept. 2023</Citation></Reference><Reference><Citation>Jason LA, Dorri JA. ME/CFS and post-Exertional malaise among patients with long COVID. Neurol Int. 2022;15:1&#x2013;11. doi: 10.3390/neurolint15010001.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/neurolint15010001</ArticleId><ArticleId IdType="pmc">PMC9844405</ArticleId><ArticleId IdType="pubmed">36648965</ArticleId></ArticleIdList></Reference><Reference><Citation>KBV (2023) &#xd6;ffentliche Anh&#xf6;rung im Ausschuss f&#xfc;r Gesundheit des Dt. Bundestages am 19.&#xa0;April 2023. https://www.bundestag.de/resource/blob/943000/60468062de2e557ef6436afb4e5c9173/20_14_0095-5-_Kassenaerztliche-Bundesvereinigung_ME-CFS_nicht-barrierefrei-data.pdf. Zugegriffen: 16. Sept. 2023 (Stellungnahme der KBV zum Antrag der CDU/CSU-Bundestagsfraktion &#x201e;ME/CFS-Bretroffene sowie deren Angeh&#xf6;rigen helfen &#x2013; F&#xfc;r eine bessere Gesundheits- sowie Therapieversorgung, Aufkl&#xe4;rung und Anerkennung&#x201c; (BT-DRS.: 20/4886 vom 14.&#xa0;Dezember 2022))</Citation></Reference><Reference><Citation>Kedor C, Freitag H, Meyer-Arndt L, et al. A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity. Nat Commun. 2022;13:5104. doi: 10.1038/s41467-022-32507-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-32507-6</ArticleId><ArticleId IdType="pmc">PMC9426365</ArticleId><ArticleId IdType="pubmed">36042189</ArticleId></ArticleIdList></Reference><Reference><Citation>Kielland A, Liu J, Jason LA (2023) Do diagnostic criteria for ME matter to patient experience with services and interventions? Key results from an online RDS survey targeting fatigue patients in Norway. J&#xa0;Health Psychol 13591053231169191:</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10619179</ArticleId><ArticleId IdType="pubmed">37114822</ArticleId></ArticleIdList></Reference><Reference><Citation>Koczulla A, Ankermann T, Behrends U, et al. S1-Leitlinie Long&#x2011;/Post-COVID. Pneumologie. 2022;76:855&#x2013;907. doi: 10.1055/a-1946-3230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/a-1946-3230</ArticleId><ArticleId IdType="pubmed">36479679</ArticleId></ArticleIdList></Reference><Reference><Citation>Kornder N, Baum E, Maisel P, et al. M&#xfc;digkeit &#x2013; Update der S3-Leitlinie. Z Allg Med. 2023;99:127&#x2013;132. doi: 10.1007/s44266-023-00045-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s44266-023-00045-z</ArticleId><ArticleId IdType="pmc">PMC10124695</ArticleId><ArticleId IdType="pubmed">37193573</ArticleId></ArticleIdList></Reference><Reference><Citation>Krymchantowski AV, Silva-Neto RP, Jevoux C, et al. Indomethacin for refractory COVID or post-COVID headache: a&#xa0;retrospective study. Acta Neurol Belg. 2022;122:465&#x2013;469. doi: 10.1007/s13760-021-01790-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13760-021-01790-3</ArticleId><ArticleId IdType="pmc">PMC8453033</ArticleId><ArticleId IdType="pubmed">34546559</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemh&#xf6;fer C, Koczulla AR, Meissner W et al (2023) Aktualisierte S1-Leitlinie Long/Post-COVID: Relevante Aspekte f&#xfc;r die Schmerzmedizin. Schmerz: 1&#x2013;8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10019417</ArticleId><ArticleId IdType="pubmed">36929455</ArticleId></ArticleIdList></Reference><Reference><Citation>Nacul L, Authier FJ, Scheibenbogen C, et al. European Network on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (EUROMENE): Expert Consensus on the Diagnosis, Service Provision, and Care of People with ME/CFS in Europe. Med (Kaunas) 2021 doi: 10.3390/medicina57050510.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina57050510</ArticleId><ArticleId IdType="pmc">PMC8161074</ArticleId><ArticleId IdType="pubmed">34069603</ArticleId></ArticleIdList></Reference><Reference><Citation>NICE (2021) Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management. https://www.nice.org.uk/guidance/ng206. Zugegriffen: 16. Sept. 2023 (Methods)</Citation></Reference><Reference><Citation> (2023) Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK: 30&#xa0;March 2023. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/datasets/alldatarelatingtoprevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk. Zugegriffen: 16. Sept. 2023 (An additional data table contains the data covering the four weeks to 2025 February 2023. Experimental Statistics.)</Citation></Reference><Reference><Citation>Peo LC, Wiehler K, Paulick J et al (2023) Pediatric and Adult Patients with ME/CFS following COVID-19: A&#xa0;Structured Approach to Diagnosis Using the Munich Berlin Symptom Questionnaire (MBSQ). 10.1101/2023.08.23.23293081 (medRxiv:2023.2008. 2023.23293081)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10951047</ArticleId><ArticleId IdType="pubmed">38095713</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfingsten M, Arnold B, Boger A, et al. Cross-sectoral interdisciplinary multimodal pain therapy : Recommendations on structural and process parameters of the ad hoc commission &#x201c;Interdisciplinary Multimodal Pain Therapy&#x201d; of the German Pain Society (Deutsche Schmerzgesellschaft e. V.) Schmerz. 2019;33:191&#x2013;203. doi: 10.1007/s00482-019-0374-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00482-019-0374-2</ArticleId><ArticleId IdType="pubmed">31073760</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajan S, Khunti K, Alwan N et&#xa0;al (2021) In the wake of the pandemic: preparing for long COVID. https://apps.who.int/iris/handle/10665/339629. Zugegriffen: 16. Sept. 2023</Citation><ArticleIdList><ArticleId IdType="pubmed">33877759</ArticleId></ArticleIdList></Reference><Reference><Citation>Renz-Polster H, Scheibenbogen C. Post-COVID syndrome with fatigue and exercise intolerance: myalgic encephalomyelitis/chronic fatigue syndrome. Inn Med (heidelb) 2022;63:830&#x2013;839.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9281337</ArticleId><ArticleId IdType="pubmed">35925074</ArticleId></ArticleIdList></Reference><Reference><Citation>Roessler M, Tesch F, Batram M, et al. Post-COVID-19-associated morbidity in children, adolescents, and adults: A&#xa0;matched cohort study including more than 157,000 individuals with COVID-19 in Germany. PLoS Med. 2022;19:e1004122. doi: 10.1371/journal.pmed.1004122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1004122</ArticleId><ArticleId IdType="pmc">PMC9648706</ArticleId><ArticleId IdType="pubmed">36355754</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheibenbogen C, Bellmann-Strobl J, Rei&#xdf;hauer A et al (2023) Myalgische Enzephalomyelitis/Chronisches Fatigue-Syndrom: Interdisziplin&#xe4;r versorgen. Dtsch &#xc4;tzteblatt: A908&#x2013;A914</Citation></Reference><Reference><Citation>Scheibenbogen C, Renz-Polster H, Hohberger B et al (2023) Post COVID und Post-Vakzin-Syndrom: Die Pandemie nach der Pandemie. Dtsch &#xc4;rztebl: A566&#x2013;A570</Citation></Reference><Reference><Citation>Scheibenbogen C, Wittke K, Hanitsch L, et al. Chronisches Fatigue Syndrom/CFS: Praktische Empfehlungen zur Diagnostik und Therapie. &#xc4;rztebl Sachsen. 2019;9:26&#x2013;30.</Citation></Reference><Reference><Citation>Sch&#xf6;ning D (2023) Long Covid Deutschland. https://longcoviddeutschland.org/ambulanzen/. Zugegriffen: 16. Sept. 2023</Citation></Reference><Reference><Citation>Tana C, Bentivegna E, Cho SJ, et al. Long COVID headache. J Headache Pain. 2022;23:93. doi: 10.1186/s10194-022-01450-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10194-022-01450-8</ArticleId><ArticleId IdType="pmc">PMC9340759</ArticleId><ArticleId IdType="pubmed">35915417</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Campen C, Rowe PC, Visser FC. Low sensitivity of abbreviated tilt table testing for diagnosing postural tachycardia syndrome in adults with ME/CFS. Front Pediatr. 2018;6:349. doi: 10.3389/fped.2018.00349.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2018.00349</ArticleId><ArticleId IdType="pmc">PMC6250822</ArticleId><ArticleId IdType="pubmed">30505831</ArticleId></ArticleIdList></Reference><Reference><Citation>Vink M, Vink-Niese A. The draft updated NICE guidance for ME/CFS highlights the unreliability of subjective outcome measures in non-blinded trials. J Health Psychol. 2022;27:9&#x2013;12. doi: 10.1177/1359105321990810.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1359105321990810</ArticleId><ArticleId IdType="pubmed">33506707</ArticleId></ArticleIdList></Reference><Reference><Citation>Vink M, Vink-Niese A (2022) The Updated NICE Guidance Exposed the Serious Flaws in CBT and Graded Exercise Therapy Trials for ME/CFS. Healthc (basel) 10:</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9141828</ArticleId><ArticleId IdType="pubmed">35628033</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams LD, Zis P. COVID-19-related burning eye syndrome and burning mouth syndrome: a&#xa0;systematic review and meta-analysis. Pain Ther. 2023;12:621&#x2013;630. doi: 10.1007/s40122-023-00492-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40122-023-00492-3</ArticleId><ArticleId IdType="pmc">PMC10012304</ArticleId><ArticleId IdType="pubmed">36917411</ArticleId></ArticleIdList></Reference><Reference><Citation>Wirth KJ, Scheibenbogen C, Paul F. An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. J Transl Med. 2021;19:471. doi: 10.1186/s12967-021-03143-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-021-03143-3</ArticleId><ArticleId IdType="pmc">PMC8607226</ArticleId><ArticleId IdType="pubmed">34809664</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>